Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Oncology Ventures is a venture capital firm founded by Ben Freeberg, a cancer survivor, dedicated to investing in healthcare data companies that address significant challenges in cancer care. Established in the United States, the firm focuses on improving early detection, ensuring guideline-based care, and enhancing the overall infrastructure of cancer treatment. Oncology Ventures aims to transform the oncology landscape through innovative solutions that can significantly impact patient outcomes.
The firm currently manages a portfolio of seven notable companies, reflecting its commitment to funding innovations that can mitigate the fragmented and costly nature of the U.S. oncology system. Oncology Ventures is strategically positioned to leverage its expertise and personal insights from the founder's experiences to identify and support startups that align with its mission.
Oncology Ventures targets technologies that address various aspects of cancer care, including early detection, patient navigation, data access, and AI-powered treatment optimization. The firm seeks to invest in healthcare data companies that can tackle the inefficiencies and high costs associated with the U.S. oncology system. Their investment thesis emphasizes funding innovations that can transform the cancer care journey from diagnosis to survivorship.
Investments are directed towards startups that demonstrate the potential to improve operational efficiency, enhance patient adherence to treatment, and provide mental health support for cancer patients. Oncology Ventures looks for founders who are passionate about making a difference in the oncology space and who possess a clear vision for their technology's impact on cancer care.
Oncology Ventures has invested in a diverse range of companies that are making significant strides in cancer care. Notable portfolio companies include:
These companies exemplify Oncology Ventures' commitment to funding innovations that can significantly impact the oncology landscape and improve patient care.
Ben Freeberg: Founder and Managing Partner. Ben has personal experience as a cancer survivor, which informs his investment strategy and focus on improving cancer care.
Nandita Kotwani: Venture Associate. Nandita supports the investment process and works closely with portfolio companies to drive growth.
Khail Macadaeg: Executive Assistant. Khail manages administrative tasks and supports the team in various operational capacities.
Jay Freeberg, CPA, CFP, MBA: Chief Financial Officer. Jay oversees financial operations and ensures the firm’s fiscal health.
Sebastian Rositano, MBBS MPH: Venture Partner. Sebastian brings expertise in healthcare and public health to the investment team.
Ethan Zohn: Venture Partner. Ethan contributes his experience in entrepreneurship and venture capital to support portfolio companies.
To pitch Oncology Ventures, founders should visit their website at oncology.ventures. It is recommended to include a detailed overview of the technology, its application in cancer care, and the team behind the project. Response times may vary, so patience is advised after submission.
What investment criteria does Oncology Ventures use?
Oncology Ventures focuses on healthcare data companies that address significant challenges in cancer care, particularly those that improve early detection, patient navigation, and treatment optimization through technology.
How can I pitch to Oncology Ventures?
Founders can submit their pitches through the Oncology Ventures website at oncology.ventures. It is advisable to include a clear explanation of how the technology addresses specific challenges in cancer care.
What makes Oncology Ventures different from other investors?
The firm is founded by Ben Freeberg, a cancer survivor, which provides a unique perspective on the challenges faced in oncology. This personal experience drives their commitment to improving cancer care through data-driven solutions.
What is the geographic focus of Oncology Ventures?
Oncology Ventures primarily invests in companies based in the United States, targeting innovations that can address the specific needs of the U.S. oncology system.
What is the typical check size for investments?
While specific check sizes are not disclosed, Oncology Ventures typically invests in early-stage companies that demonstrate potential for significant impact in cancer care.
What kind of post-investment support does Oncology Ventures provide?
Oncology Ventures actively engages with portfolio companies to provide operational support, mentorship, and guidance in navigating the complexities of the healthcare landscape.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.